Monday 9 November 2026 Export LTGO’s income statement to Excel — free account

Latigo Biotherapeutics Inc

LTGO

Healthcare Biotechnology

Insider buying

13.62 1.02 +8.10%

Follow LTGO

Alert me

Market cap: $835.4M
P/E: —
Fwd P/E: —
Dividend yield: —
F-score: n/a
ROIC: 0.00%
Net debt / EBITDA: —
Dividend safety: n/a

Overview

	Dec '25
ROE Full definition →	0.00%
ROA Full definition →	0.00%
Return on Tangible Assets Full definition →	0.00%
Free Cash Flow per Share Full definition →	0.00
Cash per Share Full definition →	0.00
Shareholders Equity per Share Full definition →	0.00
Interest Debt per Share Full definition →	0.00
Book value per Share Full definition →	0.00
Other line items
Debt/Assets Full definition →	0.00%
Operating CF/Net income Full definition →	0.00
Intangible Assets out of Total Assets Full definition →	0.00
Revenue per Share Full definition →	0.00
Operating CF per Share Full definition →	0.00
Capex per Share Full definition →	0.00

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026